Medicine and Health
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies
M. Labrie, A. Li, et al.
This pilot study dives into real-time deep analysis of tumor samples from triple-negative breast cancer patients to uncover resistance mechanisms and potential treatments with PARP inhibitors. Highlighting heterogeneity in responses, the research reveals a promising link between immune activation and therapy benefits. Conducted by Marilyne Labrie and colleagues, discover the nuances of TNBC treatment!
Related Publications
Explore these studies to deepen your understanding of the subject.

